1. Home
  2. LINC vs PGEN Comparison

LINC vs PGEN Comparison

Compare LINC & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$40.94

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
PGEN
Founded
1946
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
LINC
PGEN
Price
$40.94
$4.12
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$45.00
$8.33
AVG Volume (30 Days)
310.3K
2.8M
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
0.64
N/A
Revenue
$261,853,000.00
$230,981,000.00
Revenue This Year
$15.16
$1,115.92
Revenue Next Year
$9.02
$81.04
P/E Ratio
$64.10
N/A
Revenue Growth
32.98
N/A
52 Week Low
$17.29
$1.23
52 Week High
$42.85
$5.47

Technical Indicators

Market Signals
Indicator
LINC
PGEN
Relative Strength Index (RSI) 56.03 54.94
Support Level $38.92 $3.91
Resistance Level $42.69 $4.31
Average True Range (ATR) 1.57 0.19
MACD -0.14 0.00
Stochastic Oscillator 53.81 64.01

Price Performance

Historical Comparison
LINC
PGEN

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include: Campus Operations and Transitional. The majority of the revenue is generated from the Campus Operations segment, which includes all campuses that are continuing in operation and contribute to the company's core operations and performance.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: